title: Reticulate scleroderma after isolated limb perfusion with melphalan.
authors.affiliation: Department of Dermatology, Tel Aviv--Elias Sourasky Medical Center, and Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Landau
authors.forename: S
authors.initials: S
authors.lastname: Brenner
authors.forename: A
authors.initials: A
authors.lastname: Gat
authors.forename: J M
authors.initials: JM
authors.lastname: Klausner
authors.forename: M
authors.initials: M
authors.lastname: Gutman
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D006801:Humans; D007871:Leg Ulcer / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000009:adverse effects*; D008875:Middle Aged; D010477:Perfusion; D012509:Sarcoma / Q000188:drug therapy; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000473:pathology
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan